Health
Neurocrine Biosciences and Rare Disease Treatments
Neurocrine Biosciences faces a delicate balance in the development of rare disease treatments, as patients must weigh potential benefits against risks.
Coverage timeline — 1 article
STAT News
When it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.
2026-08-13 10:30 UTC